BioForce Nanosciences Financials
| BFNH Stock | USD 0.34 0.25 42.37% |
BioForce |
Understanding current and past BioForce Nanosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioForce Nanosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in BioForce Nanosciences' assets may result in an increase in income on the income statement.
BioForce Nanosciences Stock Summary
BioForce Nanosciences competes with Bit Origin, Blue Star, Better Choice, and Stryve Foods. BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US09064C2061 |
| Business Address | 2020 General Booth |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Benchmark | Dow Jones Industrial |
| Website | www.bioforceeclipse.com |
| Phone | 757 306 6090 |
| Currency | USD - US Dollar |
BioForce Nanosciences Key Financial Ratios
BioForce Nanosciences' financial ratios allow both analysts and investors to convert raw data from BioForce Nanosciences' financial statements into concise, actionable information that can be used to evaluate the performance of BioForce Nanosciences over time and compare it to other companies across industries.| Return On Asset | -21.84 | |||
| Target Price | 0.25 | |||
| Beta | -1.93 |
BioForce Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioForce Nanosciences's current stock value. Our valuation model uses many indicators to compare BioForce Nanosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioForce Nanosciences competition to find correlations between indicators driving BioForce Nanosciences's intrinsic value. More Info.BioForce Nanosciences Holdings is rated below average in return on asset category among its peers. It is the top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioForce Nanosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioForce Nanosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioForce Nanosciences Systematic Risk
BioForce Nanosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioForce Nanosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on BioForce Nanosciences correlated with the market. If Beta is less than 0 BioForce Nanosciences generally moves in the opposite direction as compared to the market. If BioForce Nanosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioForce Nanosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioForce Nanosciences is generally in the same direction as the market. If Beta > 1 BioForce Nanosciences moves generally in the same direction as, but more than the movement of the benchmark.
BioForce Nanosciences January 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioForce Nanosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioForce Nanosciences Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioForce Nanosciences Holdings based on widely used predictive technical indicators. In general, we focus on analyzing BioForce Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioForce Nanosciences's daily price indicators and compare them against related drivers.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 60.56 | |||
| Value At Risk | (14.91) | |||
| Potential Upside | 7.14 |
Complementary Tools for BioForce Pink Sheet analysis
When running BioForce Nanosciences' price analysis, check to measure BioForce Nanosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioForce Nanosciences is operating at the current time. Most of BioForce Nanosciences' value examination focuses on studying past and present price action to predict the probability of BioForce Nanosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioForce Nanosciences' price. Additionally, you may evaluate how the addition of BioForce Nanosciences to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |